Skip to main content

Advertisement

SpringerLink
Log in

A fatal case of Strongyloides hyperinfection with obscure risk factors

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

All relevant data is included in the manuscript.

References

  1. Buonfrate D, Bisanzio D, Giorli G, Odermatt P, Fürst T, Greenaway C et al (2020) The global prevalence of Strongyloides stercoralis infection. Pathogens 9:468. https://doi.org/10.3390/pathogens9060468

    Article  PubMed  PubMed Central  Google Scholar 

  2. World Health Organization (2020) Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021–2030. WHO. Accessed December 27, 2022. https://www.who.int/publications/i/item/9789240010352

  3. Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H et al (2013) Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7:e2288. https://doi.org/10.1371/journal.pntd.0002288

  4. Kaminsky RLG, Reyes-García SZ, Zambrano LI (2016) Unsuspected Strongyloides stercoralis infection in hospital patients with comorbidity in need of proper management. BMC Infect Dis 16:98. https://doi.org/10.1186/s12879-016-1424-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Saugar JM, Merino FJ, Martín-Rabadán P, Fernández-Soto P, Ortega S, Gárate T et al (2015) Application of real-time PCR for the detection of Strongyloides spp. in clinical samples in a reference center in Spain. Acta Trop 142:20–25

    Article  CAS  PubMed  Google Scholar 

  6. Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17:208–217. https://doi.org/10.1128/CMR.17.1.208-217.2004

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lappan R, Classon C, Kumar S, Singh OP, de Almeida RV, Chakravarty J et al (2019) Metataxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India. PLoS Negl Trop Dis 13(9):e0007444. https://doi.org/10.1371/journal.pntd.0007444

  8. Kolbaum J, Ritter U, Zimara N, Brewig N, Eschbach ML, Breloer M (2011) Efficient control of Leishmania and Strongyloides despite partial suppression of nematode-induced Th2 response in co-infected mice. Parasite Immunol 33(4):226–235. https://doi.org/10.1111/j.1365-3024.2010.01273.x

    Article  CAS  PubMed  Google Scholar 

  9. O’Neal SE, Guimaraes LH, Machado PR, Alcantara L, Morgan DJ, Passos S et al (2007) Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis. J Infect Dis 195(1):142–148. https://doi.org/10.1086/509808

    Article  PubMed  Google Scholar 

  10. Newlove T, Guimaraes LH, Morgan DJ, Alcantara L, Glesby MJ, Carvalho EM et al (2011) Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis. Am J Trop Med Hyg 84(4):551–555. https://doi.org/10.4269/ajtmh.2011.10-0423

    Article  PubMed  PubMed Central  Google Scholar 

  11. Buonfrate D, Salas-Coronas J, Muñoz J, Maruri BT, Rodari P, Castelli F et al (2019) Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. Lancet Infect Dis 19:1181–1190. https://doi.org/10.1016/S1473-3099(19)30289-0

    Article  CAS  PubMed  Google Scholar 

  12. Henriquez-Camacho C, Gotuzzo E, Echevarria J, Clinton White A, Terashima A, Samalvides F et al (2016) Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev CD007745. https://doi.org/10.1002/14651858.CD007745.pub3

Download references

Author information

Authors and Affiliations

  1. Department of Medical Parasitology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

    Abhishek Mewara, Rajendra Gudisa, Nikita Sharma & Rimjhim Kanaujia

Authors
  1. Abhishek Mewara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rajendra Gudisa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikita Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rimjhim Kanaujia
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception, data collection, and writing of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Abhishek Mewara.

Ethics declarations

Informed consent

The patient’s relative has consented to the submission of the case report to the journal.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mewara, A., Gudisa, R., Sharma, N. et al. A fatal case of Strongyloides hyperinfection with obscure risk factors. Eur J Clin Microbiol Infect Dis 42, 661–663 (2023). https://doi.org/10.1007/s10096-023-04588-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-023-04588-8

Search

Navigation